|
Selected
publications
Giorello L, Clerico L, Pescarolo MP, Vikhanskaya F,
Salmona M, Colella G, Bruno S, Mancuso T,
Bagnasco L, Russo P, Parodi S. Inhibition of cancer
cell growth and c-Myc transcriptional activity by a
c-
Myc helix 1-type peptide fused to an internalisation
sequence. Cancer Res 1998;58:3654-9.
Vikhanskaya F, Colella G, Valenti M, Parodi S,
D’Incalci M, Broggini M. Cooperation between
p53 and hMLH1 in a human colocarcinoma cell
line in response to DNA damage. Clin Cancer Res
1999;5:937-41.
Russo P, Ottoboni C, Falugi C, Reinhold W, Riou JF,
Parodi S, O’Connor PM. Cellular effects of a new
farnesyltransferase inhibitor, RPR-115135, in a
human isogenic colon cancer cell line model
system HCT-116. Annal NY Acad Sci 1999;886:252-6.
Alberti L, Barboro P, Barbesino M, Sanna P, Pisciotta
L,
Parodi S, Nicolò G, Boccardo F, Galli S, Patrone
E,
Balbi C. Changes in the expression of cytokeratins
and nuclear matrix proteins are correlated with the
level of differentiation in human prostate cancer. J
Cell Biochem 2000;79:471-85.
Pescarolo MP, Bagnasco L, Malacarne D, Melchiori
A, Valente P, Millo E, Bruno S, Basso S, Parodi S.
A retro-inverso peptide homologous to helix 1 of
c-Myc is a potent and specific inhibitor of
proliferation in different cellular systems. FASEB J
2001;15:31-3. |